Page 25 - TD-4-2
P. 25

Tumor Discovery                                                         Melanoma exosomes in metastasis



            64.  Gu WJ, Shen YW, Zhang LJ, et al. The multifaceted   76.  Das SK, Sarkar D, Emdad L, Fisher PB. MDA-9/Syntenin:
               involvement of exosomes in tumor progression: Induction   An emerging global molecular target regulating cancer
               and inhibition. MedComm (2020). 2021;2:297-314.    invasion and metastasis. Adv Cancer Res. 2019;144:137-191.
               doi: 10.1002/mco2.49                               doi: 10.1016/bs.acr.2019.03.011
            65.  Wang S,  Li F, Ye  T, et al. Macrophage-tumor chimeric   77.  Zhang S, et al. Mutant p53 drives cancer metastasis via RCP-
               exosomes accumulate in lymph node and tumor to activate   mediated Hsp90α secretion. Cell Rep. 2020;32:107879.
               the immune response and the tumor microenvironment. Sci
               Transl Med. 2021;13:eabb6981.                      doi: 10.1016/j.celrep.2020.107879
                                                               78.  Barreca V, Boussadia Z, Polignano D, et al. Metabolic
               doi: 10.1126/scitranslmed.abb6981
                                                                  labelling of a subpopulation of small extracellular vesicles
            66.  Liu N, Yan M, Tao Q, et al. Inhibition of TCA cycle improves   using  a  fluorescent  palmitic  acid  analogue.  J  Extracell
               the anti-PD-1 immunotherapy efficacy in melanoma cells   Vesicles. 2023;12:e12392.
               via ATF3-mediated PD-L1 expression and glycolysis.
               J Immunother Cancer. 2023;11:e007146.              doi: 10.1002/jev2.12392
                                                               79.  Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-
               doi: 10.1136/jitc-2023-007146
                                                                  ALIX regulates the biogenesis of exosomes. Nat Cell Biol.
            67.  Chen G, Huang AC, Zhang W, et al. Exosomal PD-L1   2012;14:677-685.
               contributes to immunosuppression and is associated with
               anti-PD-1 response. Nature. 2018;560:382-386.      doi: 10.1038/ncb2502
               doi: 10.1038/s41586-018-0392-8                  80.  Li Y, Chen ZK, Duan X, et al. Targeted inhibition of tumor-
                                                                  derived exosomes as a novel therapeutic option for cancer.
            68.  Daassi D, Mahoney KM, Freeman GJ. The importance   Exp Mol Med. 2022;54:1379-1389.
               of exosomal PDL1 in tumour immune evasion.  Nat Rev
               Immunol. 2020;20:209-215.                          doi: 10.1038/s12276-022-00856-3
               doi: 10.1038/s41577-019-0264-y                  81.  Linder M, Pogge von Strandmann E. The role of extracellular
                                                                  HSP70 in the function of tumor-associated immune cells.
            69.  Leary N, Walser S, He Y, et al. Melanoma-derived   Cancers (Basel). 2021;13:4721.
               extracellular vesicles mediate lymphatic remodelling
               and impair tumour immunity in draining lymph nodes.      doi: 10.3390/cancers13184721
               J Extracell Vesicles. 2022;11:e12197.           82.  Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome
               doi: 10.1002/jev2.12197                            integrins determine organotropic metastasis.  Nature.
                                                                  2015;527:329-335.
            70.  Wang X, Huang J, Chen W, Li G, Li Z, Lei J. The updated
               role of exosomal proteins in the diagnosis, prognosis, and      doi: 10.1038/nature15756
               treatment of cancer. Exp Mol Med. 2022;54:1390-1400.  83.  Mirzaei H, Gholamin S, Shahidsales S, et al. MicroRNAs
               doi: 10.1038/s12276-022-00855-4                    as  potential  diagnostic  and  prognostic  biomarkers in
                                                                  melanoma. Eur J Cancer. 2016;53:25-32.
            71.  Ricciardi E, Giordani E, Ziccheddu G, et al. Metastatic
               melanoma: Liquid biopsy as a new precision medicine      doi: 10.1016/j.ejca.2015.10.009
               approach. Int J Mol Sci. 2023;24:4014.          84.  Mao L, Liu S, Chen Y, Huang H, Ding F, Deng L. Engineered
               doi: 10.3390/ijms24044014                          exosomes: A  potential therapeutic strategy for septic
                                                                  cardiomyopathy. Front Cardiovasc Med. 2024;11:1399738.
            72.  Gajos-Michniewicz A, Duechler M, Czyz M. MiRNA in
               melanoma-derived exosomes. Cancer Lett. 2014;347:29-37.     doi: 10.3389/fcvm.2024.1399738
               doi: 10.1016/j.canlet.2014.02.004               85.  Zhong W, Lu Y, Han X, et al. Upregulation of exosome
                                                                  secretion  from  tumor-associated  macrophages  plays  a
            73.  Rehman AU, Khan P, Maurya SK, et al. Liquid biopsies to   key role in the suppression of anti-tumor immunity.  Cell
               occult brain metastasis. Mol Cancer. 2022;21:113.  Rep. 2023;42:113224.
               doi: 10.1186/s12943-022-01577-x                    doi: 10.1016/j.celrep.2023.113224
            74.  Bayat M, Sadri Nahand J. Exosomal miRNAs: The tumor’s   86.  Pu Y, Ji Q. Tumor-associated macrophages regulate
               trojan horse in selective metastasis. Mol Cancer. 2024;23:167.  PD-1/PD-L1  immunosuppression.  Front  Immunol.
               doi: 10.1186/s12943-024-02081-0                    2022;13:874589.
            75.  Li Z, Fang R, Fang J, He S, Liu T. Functional implications of      doi: 10.3389/fimmu.2022.874589
               Rab27 GTPases in cancer. Cell Commun Signal. 2018;16:44.
                                                               87.  Paolino D, Celia C, Trapasso E, Cilurzo F, Fresta M.
               doi: 10.1186/s12964-018-0255-9                     Paclitaxel-loaded ethosomes®: Potential treatment of


            Volume 4 Issue 2 (2025)                         17                                doi: 10.36922/td.7108
   20   21   22   23   24   25   26   27   28   29   30